Evidence map›Paper›PMID 40034643›Full record

ArticleCureus2025

Purpura Annularis Telangiectodes of Majocchi Following a Booster Dose of the Pfizer-BioNTech COVID-19 Vaccine: Coincidence or Correlation?

Amal Al Salmi, Abdullah Al Shibli, Maimuna Al-Saadi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amal Al SalmiDermatology, Al Buraimi Hospital, Al Buraimi, OMN.
Abdullah Al ShibliFamily Medicine, Oman Medical Specialty Board, Muscat, OMN.
Maimuna Al-SaadiPathology, Khoula Hospital, Muscat, OMN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the widespread distribution of COVID-19 vaccines, a range of side effects have been reported globally. These effects range from mild reactions, such as injection site discomfort and fever, to rarer events like allergic responses. While most side effects have been mild and transient, their occurrence has prompted further investigation into their frequency, severity, and underlying mechanisms. Despite the generally favorable safety profile of current vaccines, ongoing research remains essential to ensuring their continued safety and effectiveness across diverse populations. In this paper, we present the case of a 25-year-old female diagnosed with purpura annularis telangiectodes of Majocchi following a booster dose of the Pfizer-BioNTech COVID-19 mRNA vaccine. Whether this represents a causal association or a coincidental occurrence warrants further investigation.

Indexed as

covid-19 vaccinepfizer-biontech vaccinepigmented purpuric dermatosispurpura annularis telangiectodes of majocchiside effects

Identifiers

PMID40034643
PMCPMC11874453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.